1h Free Analyst Time
The cardiac biomarkers market is forecasted to grow by USD 9.02 billion during 2023-2028, accelerating at a CAGR of 12.88% during the forecast period. The report on the cardiac biomarkers market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing prevalence of CVDs, growing geriatric population, and rising number of M&A and new product launches.
The cardiac biomarkers market is segmented as below:
By Technology
- Conventional laboratory testing
- POC testing
By Product
- Troponin
- BNP and NT-proBNP
- CK-MB
- Myoglobin
- Others
By End-user
- Hospitals and clinics
- Diagnostic laboratories
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the cardiac biomarkers market covers the following areas:
- Cardiac biomarkers market sizing
- Cardiac biomarkers market forecast
- Cardiac biomarkers market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Technology
7 Market Segmentation by Product
8 Market Segmentation by End-user
9 Customer Landscape
10 Geographic Landscape
11 Drivers, Challenges, and Opportunity/Restraints
12 Competitive Landscape
13 Competitive Analysis
14 Appendix
List of Exhibits
Executive Summary
The following companies are recognized as the key players in the global cardiac biomarkers market: Abbott Laboratories, Advanced ImmunoChemical Inc., AgPlus Diagnostics Ltd., BG Medicine Inc., Bio RAD Laboratories Inc., bioMerieux SA, Boditech Med Inc., Creative Diagnostics, Danaher Corp., Diazyme Laboratories Inc., F. Hoffmann La Roche Ltd., Lepu Medical Technology Beijing Co. Ltd., LifeSign LLC, LSI Medience Corp., Noavaran Payesh Aani Salamat. Co., Oy Medix Biochemica Ab, Randox Laboratories Ltd., Response Biomedical Corp., Siemens Healthineers AG, Signosis Inc., and Tosoh Corp..Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is increased focus on personalized medicine."
According to the report, one of the major drivers for this market is the increasing prevalence of CVDs.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Abbott Laboratories
- Advanced ImmunoChemical Inc.
- AgPlus Diagnostics Ltd.
- BG Medicine Inc.
- Bio Rad Laboratories Inc.
- bioMerieux SA
- Boditech Med Inc.
- Creative Diagnostics
- Danaher Corp.
- Diazyme Laboratories Inc.
- F. Hoffmann La Roche Ltd.
- Lepu Medical Technology Beijing Co. Ltd.
- LifeSign LLC
- LSI Medience Corp.
- Noavaran Payesh Aani Salamat. Co.
- Oy Medix Biochemica Ab
- Randox Laboratories Ltd.
- Response Biomedical Corp.
- Siemens Healthineers AG
- Signosis Inc.
- Tosoh Corp.
